Show all Events 29 Jun 2026 5:00 PM EDT Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions 03 Jun 2026 11:40 AM EDT Jefferies Global Healthcare Conference 02 Jun 2026 9:00 AM EDT William Blair 46th Annual Growth Stock Conference 30 Apr 2026 9:30 AM AEST Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach 17 Mar 2026 3:00 PM EDT HCW @ Home with Telix Pharmaceuticals All Events Presentations Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions All Presentations News 24 Jul 2026 Change in substantial holding 21 Jul 2026 TLX591-Tx ProstACT SELECT Study Published in Cancers Journal 21 Jul 2026 Q2 2026 Revenue US$247M Strong Momentum Pipeline Progress 20 Jul 2026 Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer 15 Jul 2026 First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer All News Releases
29 Jun 2026 5:00 PM EDT Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
30 Apr 2026 9:30 AM AEST Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach